Complete Emerging Biopharma Trials Faster
As an emerging or mid-sized biopharma, you’re advancing complex science under tight timelines and investor pressure.
Medidata brings the experience of more than 38,000 clinical trials to a scalable, unified platform—so you can design, run, and close studies with the speed, compliance, and control you need without adding operational burden.
Expert Support Built for Emerging Biopharma
You need a partner who understands the realities of device and diagnostic development—across therapeutic areas, regulatory pathways, and evolving evidence requirements.
Therapeutic Depth
Unified Cloud-based Solution
Medidata Consult Program for Flexible Resourcing
End‑to‑end Support
What Makes Medidata Different?
AI-driven Oversight
Get a 360° View of the Patient
AI-driven oversight gives a more accurate view of the patient—delivering faster, safer trials more efficiently.
Discover Clinical Data Studio
What Customers Say
Medidata’s expert team streamlined the entire URL ownership process and gave us a blueprint for effectively building our own studies from the ground up.
Summer Acevedo
Clinical Trial Manager
Through the platform’s intuitive interface, our research teams can confidently navigate the complexities of the trial to ensure all data elements are captured efficiently. Medidata has also helped reduce the administrative burden of data collection, allowing the research teams to focus on patient outcomes.
Jenna Brager PhD, RN
Executive VP
The [Medidata] team, whether it’s on a technical level or a service level, has been very smooth, very responsive, and I always get help when we do an EDC build. They have input and suggestions on what we should and should not do to overcomplicate the study build.
Salam Ammus
Executive Director, Clinical Data Management
Featured Resource
Everest Group’s 2026 AI Innovation Watch
Everest Group's 2026 Innovation Watch report unveils new framework for evaluating AI providers, recognizes Medidata as top-rated “Luminary.”
Download Report